Are you Dr. Villablanca?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 63 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4650 W Sunset Blvd
Los Angeles, CA 90027Phone+1 323-669-2121Fax+1 323-660-7128
Summary
- Dr. Judith Villablanca, MD is a pediatric hematologist/oncologist in Los Angeles, California. She is currently licensed to practice medicine in California. She is affiliated with Children's Hospital Los Angeles.
Education & Training
- University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1986 - 1989
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1983 - 1986
- University of Michigan Medical SchoolClass of 1983
Certifications & Licensure
- CA State Medical License 1984 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Fenretinide in Treating Children With Solid Tumors Start of enrollment: 1998 Mar 01
- Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma Start of enrollment: 2003 May 01
- N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma Start of enrollment: 2005 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 37 citationsLorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.Kelly C Goldsmith, Julie R Park, Kimberly Kayser, Jemily Malvar, Yueh-Yun Chi
Nature Medicine. 2023-05-01 - 3 citationsEarly-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National...Julie R Park, Judith G Villablanca, Barbara Hero, Brian H Kushner, Keith Wheatley
Cancer. 2022-11-01 - 1 citationsExpression of neuroblastoma-related genes in bone marrow at end of high-risk neuroblastoma therapy.Shahab Asgharzadeh, Araz Marachelian, Judith G Villablanca, Wei Yao Liu, Rebekah Kennedy
Pediatric Blood & Cancer. 2022-09-01